US 12,214,105 B2
Long lasting biodegradable polymer based in-situ forming implant for treatment of bone injuries
Fatma Samir Abd El-Salam El-Sebaie, Giza (EG); Seham Abd Elkhalek Elkheshen, Cairo (EG); Azza Ahmed Mohamed Mahmoud, Cairo (EG); Nermeen Adel Ahmed Elkasabgy, Giza (EG); Emad Basalious Bashir Basalious, Cairo (EG); Amany Abdel Monem Mostafa Abdel Rahman, Giza (EG); and Mohammed Said Mostafa Amer, Giza (EG)
Assigned to FUTURE UNIVERSITY IN EGYPT, New Cairo (EG)
Appl. No. 17/436,862
Filed by FUTURE UNIVERSITY IN EGYPT, New Cairo (EG)
PCT Filed Mar. 5, 2019, PCT No. PCT/EG2019/050002
§ 371(c)(1), (2) Date Sep. 7, 2021,
PCT Pub. No. WO2020/177830, PCT Pub. Date Sep. 10, 2020.
Prior Publication US 2022/0152270 A1, May 19, 2022
Int. Cl. A61L 27/18 (2006.01); A61K 31/4535 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01)
CPC A61L 27/18 (2013.01) [A61K 31/4535 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01)] 10 Claims
OG exemplary drawing
 
1. An In-situ forming implant formulation comprising: poly (lactide-co-glycolide) (PLGA) copolymer in concentration range from 5% to 20% w/v, a selective estrogen receptor modulator, 1-monolinolein in concentration range from 5% to 10% w/v, and an organic solvent.